
Futura Medical plc – LSE:FUM.L
Futura Medical stock price today
Futura Medical stock price monthly change
Futura Medical stock price quarterly change
Futura Medical stock price yearly change
Futura Medical key metrics
Market Cap | 96.11M |
Enterprise value | N/A |
P/E | -21.27 |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | 3653.75 |
Price/Book | 11.80 |
PEG ratio | 0.25 |
EPS | -0.04 |
Revenue | N/A |
EBITDA | -18.49M |
Income | -12.35M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -34235.89% |
Oper. margin | -42752.63% |
Gross margin | 0% |
EBIT margin | -42752.63% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeFutura Medical stock price history
Futura Medical stock forecast
Futura Medical financial statements
Jun 2022 | 0 | -2.49M | |
---|---|---|---|
Dec 2022 | 0 | -3.34M | |
Jun 2023 | 1.70M | -1.75M | -103.27% |
Dec 2023 | 1.39M | -4.75M | -339.95% |
2027 | 38.59M | 18.61M | 48.24% |
---|
Analysts Price target
Financials & Ratios estimates
Jun 2022 | 8766083 | 1.38M | 15.84% |
---|---|---|---|
Dec 2022 | 6472662 | 1.75M | 27.08% |
Jun 2023 | 10207540 | 2.19M | 21.51% |
Dec 2023 | 11816353 | 6.33M | 53.65% |
Dec 2021 | -1.99M | -418.34K | 24.80K |
---|---|---|---|
Jun 2022 | -3.41M | -301.62K | 21.83K |
Dec 2022 | -2.35M | -439.07K | 147.75K |
Jun 2023 | -587.11K | -6.88K | 4.40M |
Futura Medical alternative data
Aug 2023 | 12 |
---|---|
Sep 2023 | 12 |
Oct 2023 | 12 |
Nov 2023 | 12 |
Dec 2023 | 12 |
Jan 2024 | 12 |
Feb 2024 | 12 |
Mar 2024 | 12 |
Apr 2024 | 12 |
May 2024 | 12 |
Jun 2024 | 12 |
Jul 2024 | 12 |
Futura Medical other data
Insider | Compensation |
---|---|
Mr. James Henry Barder (1960) Chief Executive Officer & Executive Director | $309,310 |
Mr. Kenneth William James (1953) Head of R&D & Executive Director | $248,220 |
-
What's the price of Futura Medical stock today?
One share of Futura Medical stock can currently be purchased for approximately $39.3.
-
When is Futura Medical's next earnings date?
Unfortunately, Futura Medical's (FUM.L) next earnings date is currently unknown.
-
Does Futura Medical pay dividends?
No, Futura Medical does not pay dividends.
-
How much money does Futura Medical make?
Futura Medical has a market capitalization of 96.11M.
-
What is Futura Medical's stock symbol?
Futura Medical plc is traded on the LSE under the ticker symbol "FUM.L".
-
What is Futura Medical's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Futura Medical?
Shares of Futura Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Futura Medical's key executives?
Futura Medical's management team includes the following people:
- Mr. James Henry Barder Chief Executive Officer & Executive Director(age: 65, pay: $309,310)
- Mr. Kenneth William James Head of R&D & Executive Director(age: 72, pay: $248,220)
-
How many employees does Futura Medical have?
As Jul 2024, Futura Medical employs 12 workers.
-
When Futura Medical went public?
Futura Medical plc is publicly traded company for more then 22 years since IPO on 22 Jul 2003.
-
What is Futura Medical's official website?
The official website for Futura Medical is futuramedical.com.
-
How can i contact Futura Medical?
Futura Medical can be reached via phone at +44 1483 685670.
Futura Medical company profile:

Futura Medical plc
futuramedical.comLSE
12
Biotechnology
Healthcare
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Guildford, GU2 7YG
:
ISIN: GB0033278473
CUSIP: G3698F100